Vaccinex (NASDAQ:VCNX) Stock Price Up 5.9% – Here’s What Happened

Vaccinex, Inc. (NASDAQ:VCNX)’s share price rose 5.9% during mid-day trading on Wednesday . The company traded as high as $1.30 and last traded at $1.26. Approximately 1,975 shares traded hands during mid-day trading, a decline of 42% from the average daily volume of 3,426 shares. The stock had previously closed at $1.19.

Vaccinex Price Performance

The stock has a market cap of $3.28 million, a price-to-earnings ratio of -0.03 and a beta of 1.10. The firm’s 50-day moving average is $2.09 and its 200 day moving average is $3.64.

Institutional Investors Weigh In On Vaccinex

A hedge fund recently raised its stake in Vaccinex stock. Point72 Asset Management L.P. lifted its position in shares of Vaccinex, Inc. (NASDAQ:VCNX) by 42.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 166,000 shares of the company’s stock after purchasing an additional 49,454 shares during the period. Point72 Asset Management L.P. owned about 9.60% of Vaccinex worth $564,000 as of its most recent SEC filing. Institutional investors own 50.11% of the company’s stock.

Vaccinex Company Profile

Vaccinex, Inc, a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead drug candidate, pepinemab, a humanized monoclonal antibody that binds and blocks the activity of SEMA4D.